| 14402 | A | 090589 | 001 | EPINEPHRINE | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | INJECTABLE | INTRAMUSCULAR, SUBCUTANEOUS | EPINEPHRINE (AUTOINJECTOR) | TEVA PHARMS USA | 0.3MG/DELIVERY | AB | ["AB"] | 2018-08-16 | Aug 16, 2018 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | ea3eef1832e9cacd5b1b1ae667961ca63e18851bb16add37098968eff5bf279c |
| 14403 | N | 019430 | 001 | EPINEPHRINE | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | INJECTABLE | INTRAMUSCULAR, SUBCUTANEOUS | EPIPEN | MYLAN SPECIALITY LP | 0.3MG/DELIVERY | AB | ["AB"] | 1987-12-22 | Dec 22, 1987 | No | Yes | Yes | RX | MYLAN SPECIALTY LP | 0bf3adb5bb7f91b18be742c35d0657fc323365ab90990bbeb9192f62f2b67846 |
| 14404 | N | 019430 | 002 | EPINEPHRINE | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | INJECTABLE | INTRAMUSCULAR, SUBCUTANEOUS | EPIPEN JR. | MYLAN SPECIALITY LP | 0.15MG/DELIVERY | AB | ["AB"] | 1987-12-22 | Dec 22, 1987 | No | Yes | Yes | RX | MYLAN SPECIALTY LP | d1e52c224df9e5a0271514462d505fc8957ea1502a07e9e8e2e1db68bed3bc92 |
| 14405 | N | 020800 | 002 | EPINEPHRINE | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | INJECTABLE | INTRAMUSCULAR, SUBCUTANEOUS | TWINJECT 0.15 | IMPAX | EQ 0.15MG/DELIVERY | | [] | 2004-05-28 | May 28, 2004 | No | No | No | DISCN | IMPAX LABORATORIES LLC | 2cfb05b345b2240e1c6f8316843bb95484e6c5c79885be9462e8cc170c23b70c |
| 14406 | N | 020800 | 001 | EPINEPHRINE | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | INJECTABLE | INTRAMUSCULAR, SUBCUTANEOUS | TWINJECT 0.3 | IMPAX | EQ 0.3MG/DELIVERY | | [] | 2003-05-30 | May 30, 2003 | No | No | No | DISCN | IMPAX LABORATORIES LLC | 7df3e6cc7282cfba10d622b3e0dc256598e2bd4f4e5c8eff2382500dead27329 |
| 14407 | A | 091193 | 001 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | EMERALD INTL LTD | 0.05MG/ML | AP | ["AP"] | 2016-05-03 | May 3, 2016 | No | No | No | RX | EMERALD INTERNATIONAL LTD | f123f144c5cf1852cc0a96c31ce3c7f8d7966924f7f9de9529cdda12711bf555 |
| 14408 | A | 091193 | 002 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | EMERALD INTL LTD | 0.5MG/ML | AP | ["AP"] | 2016-05-03 | May 3, 2016 | No | No | No | RX | EMERALD INTERNATIONAL LTD | af80d59d8f2e2d523269fe5dadedafb483305027c97f60983c9b8ff1a4c13833 |
| 14409 | A | 091193 | 003 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | EMERALD INTL LTD | 2MG/ML | AP | ["AP"] | 2016-05-03 | May 3, 2016 | No | No | No | RX | EMERALD INTERNATIONAL LTD | e382723601d3fa1abbfde76949d8279a905a55d65a08a40e084d7f58610feedc |
| 14410 | A | 210777 | 001 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | MAIA PHARMS INC | 0.05MG/ML | AP | ["AP"] | 2021-01-15 | Jan 15, 2021 | No | No | No | RX | MAIA PHARMACEUTICALS INC | 7f794b47bdf03170c5198399b8ff417355e8edbf8a67bce3ff02db1aff77b22f |
| 14411 | A | 210048 | 001 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | MAIA PHARMS INC | 0.5MG/ML | | [] | 2019-09-11 | Sep 11, 2019 | No | No | No | DISCN | MAIA PHARMACEUTICALS INC | 014e132288df2caad878c15b7944c80b191dbc11d61190bf32992ffd7ee8700d |
| 14412 | A | 210315 | 001 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | MAIA PHARMS INC | 1MG/ML | AP | ["AP"] | 2019-07-30 | Jul 30, 2019 | No | No | No | RX | MAIA PHARMACEUTICALS INC | 82cc2f50b0243bae4021923330dee877c52173c53e2ffbb4f501f7797d607d1d |
| 14413 | A | 210048 | 002 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | MAIA PHARMS INC | 2MG/ML | | [] | 2019-09-11 | Sep 11, 2019 | No | No | No | DISCN | MAIA PHARMACEUTICALS INC | e05c3b336c8831e7bd4feb5fb476cff840368c4514707aff481e444590d75d6e |
| 14414 | A | 209592 | 001 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | MYLAN LABS LTD | 0.5MG/ML | AP | ["AP"] | 2018-03-21 | Mar 21, 2018 | No | No | No | RX | MYLAN LABORATORIES LTD | 3d2e27235fa8fe9d76ad3e1a8a05c01e5e2252e49e0c1454d9ca65213cd3176a |
| 14415 | A | 209594 | 001 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | MYLAN LABS LTD | 1MG/ML | AP | ["AP"] | 2018-03-06 | Mar 6, 2018 | No | No | No | RX | MYLAN LABORATORIES LTD | a9e12fd5cd13b3f3b31fae2950520d1bb85554f21bc367d62118d71e9b7237c3 |
| 14416 | A | 209592 | 002 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | BACLOFEN | MYLAN LABS LTD | 2MG/ML | AP | ["AP"] | 2018-03-21 | Mar 21, 2018 | No | No | No | RX | MYLAN LABORATORIES LTD | 81cd2bd258a2cfc764762a3201b83009e8569f4a36af34930a178467afaac4b2 |
| 14417 | N | 020577 | 001 | CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | ELLIOTTS B SOLUTION | LUKARE MEDICAL LLC | 0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML | | [] | 1996-09-27 | Sep 27, 1996 | No | Yes | Yes | RX | LUKARE MEDICAL LLC | cec4ccfcd6ac1994c81aaf0a2155c4fc8447465eb1db45af05eec26550481cb3 |
| 14418 | N | 022462 | 001 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | GABLOFEN | PIRAMAL CRITICAL | 0.05MG/ML | AP | ["AP"] | 2010-11-19 | Nov 19, 2010 | No | Yes | Yes | RX | PIRAMAL CRITICAL CARE INC | ecae2d2c2636e2e4f59af6a74146e8109c444cdeca4ddd5d7bddfbd2598db0fb |
| 14419 | N | 022462 | 002 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | GABLOFEN | PIRAMAL CRITICAL | 0.5MG/ML | AP | ["AP"] | 2010-11-19 | Nov 19, 2010 | No | Yes | Yes | RX | PIRAMAL CRITICAL CARE INC | 72d4a29b1b757df990ce669df65e8fa0eecb7090a0c3fbb183d047ef39fe5e8e |
| 14420 | N | 022462 | 004 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | GABLOFEN | PIRAMAL CRITICAL | 1MG/ML | AP | ["AP"] | 2012-06-22 | Jun 22, 2012 | No | Yes | Yes | RX | PIRAMAL CRITICAL CARE INC | 0e54b2e7d68e3bc90a9cbdc056149166f0bcc99341dd590affdaf17e0e764fe0 |
| 14421 | N | 022462 | 003 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | GABLOFEN | PIRAMAL CRITICAL | 2MG/ML | AP | ["AP"] | 2010-11-19 | Nov 19, 2010 | No | Yes | Yes | RX | PIRAMAL CRITICAL CARE INC | 69aa6b401bb51711f0bbaa0bbe3b2a16b1ec89d4dc6a05f0963929e6b10bfd62 |
| 14422 | N | 050505 | 001 | GENTAMICIN SULFATE | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | GARAMYCIN | SCHERING | EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | SCHERING CORP SUB SCHERING PLOUGH CORP | 475d71b4d6c4744951c796c16d73da2aea121b1ee1b999ece4d40bcc905b94f7 |
| 14423 | N | 020075 | 003 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | LIORESAL | SAOL THERAPS RES LTD | 0.05MG/ML | AP | ["AP"] | 1996-11-07 | Nov 7, 1996 | No | Yes | Yes | RX | SAOL THERAPEUTICS RESEARCH LTD | a284d458ae3f6dc8f37e97863c51ee1b7b5eae78cde3f1a1506b48f139b21213 |
| 14424 | N | 020075 | 001 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | LIORESAL | SAOL THERAPS RES LTD | 0.5MG/ML | AP | ["AP"] | 1992-06-17 | Jun 17, 1992 | No | Yes | Yes | RX | SAOL THERAPEUTICS RESEARCH LTD | 98612b4fa193f3cef4b9d7b1d301b7da6a9897a77d1a937a08695e55d712b1b4 |
| 14425 | N | 020075 | 002 | BACLOFEN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | LIORESAL | SAOL THERAPS RES LTD | 2MG/ML | AP | ["AP"] | 1992-06-17 | Jun 17, 1992 | No | Yes | Yes | RX | SAOL THERAPEUTICS RESEARCH LTD | ee682f9f233af36be20694363592d089a99e85c25592c592f7b57cec8c557910 |
| 14426 | N | 017707 | 001 | INDIUM IN-111 PENTETATE DISODIUM | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | MPI INDIUM DTPA IN 111 | GE HEALTHCARE | 1mCi/ML | | [] | 1982-02-18 | Feb 18, 1982 | No | Yes | Yes | RX | GE HEALTHCARE | 4abe09c73551594165db401efa868502c7349486cb2576073bb0f7b3b040b80d |
| 14427 | N | 019580 | 001 | IOTROLAN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | OSMOVIST 190 | BAYER HLTHCARE | 40.6% | | [] | 1989-12-07 | Dec 7, 1989 | No | No | No | DISCN | BAYER HEALTHCARE PHARMACEUTICALS INC | 04fb89eeb8ac5461c4f248281ce8adc30daded83949daa217fef589a3c3664ec |
| 14428 | N | 019580 | 002 | IOTROLAN | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | OSMOVIST 240 | BAYER HLTHCARE | 51.3% | | [] | 1989-12-07 | Dec 7, 1989 | No | No | No | DISCN | BAYER HEALTHCARE PHARMACEUTICALS INC | 1782c81392853bdb55f2977b17d9430a7ee573e2f6a61c9520cc483473cafc68 |
| 14429 | N | 021060 | 002 | ZICONOTIDE ACETATE | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | PRIALT | TERSERA | 100MCG/1ML (100MCG/ML) | | [] | 2004-12-28 | Dec 28, 2004 | No | Yes | Yes | RX | TERSERA THERAPEUTICS LLC | 90ab6ed0a237884792d8078f6b788858831f7b5f05540df73b11673c63a6b3e2 |
| 14430 | N | 021060 | 003 | ZICONOTIDE ACETATE | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | PRIALT | TERSERA | 200MCG/2ML (100MCG/ML) | | [] | 2004-12-28 | Dec 28, 2004 | No | No | No | DISCN | TERSERA THERAPEUTICS LLC | c6f2fd0a2066dcb2509ca38411a35914b31c0af9fbb47efcc92015af0a75492e |
| 14431 | N | 021060 | 001 | ZICONOTIDE ACETATE | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | PRIALT | TERSERA | 500MCG/20ML (25MCG/ML) | | [] | 2004-12-28 | Dec 28, 2004 | No | Yes | Yes | RX | TERSERA THERAPEUTICS LLC | af649b4acdf7efb13449c52ed7282da9bd40fc8963f6fbb87c97007897dd7379 |
| 14432 | N | 021060 | 004 | ZICONOTIDE ACETATE | INJECTABLE;INTRATHECAL | INJECTABLE | INTRATHECAL | PRIALT | TERSERA | 500MCG/5ML (100MCG/ML) | | [] | 2004-12-28 | Dec 28, 2004 | No | Yes | Yes | RX | TERSERA THERAPEUTICS LLC | 819b39bf1379056355f69533e44c68d4e374004ef1e00e0804492881646cbe6b |
| 14433 | N | 021539 | 001 | ACETYLCYSTEINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ACETADOTE | CUMBERLAND PHARMS | 6GM/30ML (200MG/ML) | AP | ["AP"] | 2004-01-23 | Jan 23, 2004 | No | Yes | Yes | RX | CUMBERLAND PHARMACEUTICALS INC | 89899aed6e47891ba7f654b9857a4c0714fff909287184e4e36fea14a1803458 |
| 14434 | A | 203173 | 001 | ACETYLCYSTEINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ACETYLCYSTEINE | AKORN | 6GM/30ML (200MG/ML) | AP | ["AP"] | 2015-03-24 | Mar 24, 2015 | No | No | No | RX | AKORN OPERATING CO LLC | baaae1396722c262a42177f6cb729feecca33bb2e8d75448c68653720d3b9bf6 |
| 14435 | A | 207358 | 001 | ACETYLCYSTEINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ACETYLCYSTEINE | AUROBINDO PHARMA LTD | 6GM/30ML (200MG/ML) | AP | ["AP"] | 2016-02-29 | Feb 29, 2016 | No | No | No | RX | AUROBINDO PHARMA LTD | 755acb57dd32dd9f19c475a163cc5c9a9dc765ccb2ca0f303bc20cb6b8e46ec9 |
| 14436 | A | 200644 | 001 | ACETYLCYSTEINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ACETYLCYSTEINE | FRESENIUS KABI USA | 6GM/30ML (200MG/ML) | AP | ["AP"] | 2012-11-07 | Nov 7, 2012 | No | No | No | RX | FRESENIUS KABI USA LLC | 9647e290789d0d6dee9389646ec1f9fb70106473230985aed85a177b3f67b3eb |
| 14437 | A | 203624 | 001 | ACETYLCYSTEINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ACETYLCYSTEINE | MYLAN INSTITUTIONAL | 6GM/30ML (200MG/ML) | | [] | 2015-06-19 | Jun 19, 2015 | No | No | No | DISCN | MYLAN INSTITUTIONAL LLC | 2e48e98b22f5c88505ba5fd67eab0d1a4d2f1492a46abbe32284d4b43ab4747b |
| 14438 | A | 091684 | 001 | ACETYLCYSTEINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ACETYLCYSTEINE | SAGENT PHARMS INC | 6GM/30ML (200MG/ML) | AP | ["AP"] | 2017-10-31 | Oct 31, 2017 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | 0dbbf1cf05e97de19758a35da7cc1589ec6102be44f72f3d8f9c56046aa0d2b8 |
| 14439 | A | 208166 | 001 | ACETYLCYSTEINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ACETYLCYSTEINE | ZYDUS PHARMS | 6GM/30ML (200MG/ML) | AP | ["AP"] | 2018-07-20 | Jul 20, 2018 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | 43671f4032d3ea85f1fe8b669629efea50b9f765e9cf0972ae72ddcc2440e711 |
| 14440 | N | 022186 | 001 | FLUORESCEIN SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AK-FLUOR 10% | AKORN | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | AP | ["AP"] | 2008-08-08 | Aug 8, 2008 | No | Yes | No | RX | AKORN OPERATING CO LLC | 6808f8a4cb583d21703966aeead1bf4c67e40ce91a3627c1f283b03605d025ab |
| 14441 | N | 022186 | 002 | FLUORESCEIN SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AK-FLUOR 25% | AKORN | EQ 500MG BASE/2ML (EQ 250MG BASE/ML) | | [] | 2008-08-08 | Aug 8, 2008 | No | Yes | Yes | RX | AKORN OPERATING CO LLC | 16e287e9499fe0ed6a2eba91e1a3a7b2522c8eec9f1ef906fbb776079327940a |
| 14442 | N | 021372 | 002 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ALOXI | HELSINN HLTHCARE | EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2008-02-29 | Feb 29, 2008 | No | Yes | Yes | RX | HELSINN HEALTHCARE SA | 66bdc8682aba1a9f6f07f417ec38adb2293fcacc438ee72359c3f94675032cd3 |
| 14443 | N | 021372 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ALOXI | HELSINN HLTHCARE | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2003-07-25 | Jul 25, 2003 | No | Yes | Yes | RX | HELSINN HEALTHCARE SA | b570dba7994b36a82c2490e56f10d5ec2731f49568e5c1889ba3ec66aa6576a0 |
| 14444 | A | 203779 | 001 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AMMONIA N 13 | 3D IMAGING DRUG | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | AP | ["AP"] | 2015-10-19 | Oct 19, 2015 | No | No | No | RX | 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC | 8a27fbbb44944dd34e30dd013a1053de03caa48fac0d9363364b86a1ea5451bd |
| 14445 | A | 204352 | 001 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AMMONIA N 13 | BIOMEDCL RES FDN | 48.75mCi-487.5mCi/13ML (3.75-37.5mCi/ML) | AP | ["AP"] | 2015-05-01 | May 1, 2015 | No | No | No | RX | BIOMEDICAL RESEARCH FOUNDATION NORTHWEST LOUISANA | d3ae5ab81eecfaaf4c768074686286dc44ac593f638bfee4c6490d2e30d0bda1 |
| 14446 | A | 203783 | 001 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AMMONIA N 13 | BRIGHAM WOMENS HOSP | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | AP | ["AP"] | 2014-10-30 | Oct 30, 2014 | No | No | No | RX | BRIGHAM AND WOMENS HOSP INC | 6c4d837395178851b7595e53f73a2264ab6545e0107cb66a2d9efcdfcd3e499b |
| 14447 | A | 203700 | 001 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AMMONIA N 13 | CARDINAL HLTH 414 | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | AP | ["AP"] | 2013-02-25 | Feb 25, 2013 | No | No | No | RX | CARDINAL HEALTH 414 LLC | 083d877c4829385f8ac49497f40e232816c023d7d2a195ce92594d23ac4bf9c5 |
| 14448 | A | 204539 | 001 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AMMONIA N 13 | CENTRAL RADIOPHARM | 3.75-260mCi/ML | | [] | 2015-06-23 | Jun 23, 2015 | No | No | No | DISCN | CENTRAL RADIOPHARMACEUTICAL SERVICES INC | 55c7514c2d460a9400cf04592b72370106d92d9c68617c889897db0f77004a94 |
| 14449 | A | 204465 | 001 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AMMONIA N 13 | DECATUR | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | AP | ["AP"] | 2014-10-23 | Oct 23, 2014 | No | No | No | RX | DECATUR MEMORIAL HOSP | c83dc30ce3627c03f044fef7f0c8ec5f12988a361d1c072536f78c57132d1caf |
| 14450 | A | 205687 | 001 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AMMONIA N 13 | ESSENTIAL ISOTOPES | 3.75mCi-260mCi/ML | AP | ["AP"] | 2015-12-17 | Dec 17, 2015 | No | No | No | RX | ESSENTIAL ISOTOPES LLC | aa4cf2dab8b6a9f182d777921fe53904287743cc36d59d34c5d158d99ea09408 |
| 14451 | N | 022119 | 001 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | AMMONIA N 13 | FEINSTEIN | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | AP | ["AP"] | 2007-08-23 | Aug 23, 2007 | No | Yes | Yes | RX | FEINSTEIN INSTITUTE MEDICAL RESEARCH | 9059ab5c46f963d4e627cbea375b037ded72321e73676efbe6182aad9edf6be2 |